RecruitingNCT06502015
Rare condition
Acute inflammatory demyelinating polyradiculoneuropathy
12
studies recruiting now
as of 7 Sept 2026
92
studies registered in total
as of 7 Sept 2026
5
countries with a recruiting site
as of 7 Sept 2026
17 Jun 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT04829526
Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome
RecruitingNCT07653984
Cohort Study on Neuroimmune Diseases in the Reproductive Age
RecruitingPhase 3NCT07020819
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)
RecruitingNCT06940908
Living With Guillain-Barré Syndrome as Children.
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 12 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Acute inflammatory demyelinating polyradiculoneuropathy study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Acute inflammatory demyelinating polyradiculoneuropathy
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (PMP22).
Treatments being studied
8 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Nipocalimab
Phase 3Riliprubart
Phase 3Rituximab (Blitzima)
Phase 3Human Immunoglobulin G (Flebogamma dif (previously flebogammadif))
Phase 2Cyclophosphamide (Cyclophosphamide)
Phase 2Batoclimab
Phase 2Corticotropin (Acth)
Phase 2Efgartigimod Alfa (Efgartigimod alfa component of vyvgart hytrulo)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).